Anticoagulation Control with Acenocoumarol or Warfarin in Non-Valvular Atrial Fibrillation in Primary Care (Fantas-TIC Study)

Introduction: The use of vitamin K antagonists (VKAs) in non-valvular atrial fibrillation (NVAF) is complicated due to the narrow therapeutic margin they present and their unpredictable dose–response relationship. Most studies are based on warfarin, with the results being extrapolated to acenocoumar...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalmau Llorca, M. Rosa, Aguilar Martín, Carina, Carrasco-Querol, Noèlia, Hernández Rojas, Zojaina, Forcadell Drago, Emma, Rodríguez Cumplido, Dolores, Castro Blanco, Elisabet, Gonçalves, Alessandra Queiroga, Fernández-Sáez, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199061/
https://www.ncbi.nlm.nih.gov/pubmed/34073370
http://dx.doi.org/10.3390/ijerph18115700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199061/
https://www.ncbi.nlm.nih.gov/pubmed/34073370
http://dx.doi.org/10.3390/ijerph18115700

Ejemplares similares